Evidence map›Paper›PMID 31510706›Full record

ArticleBioinformatics (Oxford, England)2019

Using the structure of genome data in the design of deep neural networks for predicting amyotrophic lateral sclerosis from genotype.

Bojian Yin, Marleen Balvert, Rick A A van der Spek, Bas E Dutilh, Sander Bohté, Jan Veldink, Alexander Schönhuth

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. A survey on deep learning for polygenic risk scores.Briefings in bioinformatics · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bojian YinCentrum Wiskunde & Informatica, Life Sciences & Health, XG Amsterdam, The Netherlands.
Marleen BalvertCentrum Wiskunde & Informatica, Life Sciences & Health, XG Amsterdam, The Netherlands.
Rick A A van der SpekDepartment of Neurology, Brain Center Rudolf Magnus University Medical Center Utrecht, Utrecht, The Netherlands.
Bas E DutilhTheoretical Biology & Bioinformatics, Utrecht University, JE Utrecht, The Netherlands.
Sander BohtéCentrum Wiskunde & Informatica, Life Sciences & Health, XG Amsterdam, The Netherlands.
Jan VeldinkDepartment of Neurology, Brain Center Rudolf Magnus University Medical Center Utrecht, Utrecht, The Netherlands.
Alexander SchönhuthCentrum Wiskunde & Informatica, Life Sciences & Health, XG Amsterdam, The Netherlands.
Centrum Wiskunde & Informatica · NLUniversity Medical Center Utrecht · NLUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationAmyotrophic lateral sclerosis (ALS) is a neurodegenerative disease caused by aberrations in the genome. While several disease-causing variants have been identified, a major part of heritability remains unexplained. ALS is believed to have a complex genetic basis where non-additive combinations of variants constitute disease, which cannot be picked up using the linear models employed in classical genotype-phenotype association studies. Deep learning on the other hand is highly promising for identifying such complex relations. We therefore developed a deep-learning based approach for the classification of ALS patients versus healthy individuals from the Dutch cohort of the Project MinE dataset. Based on recent insight that regulatory regions harbor the majority of disease-associated variants, we employ a two-step approach: first promoter regions that are likely associated to ALS are identified, and second individuals are classified based on their genotype in the selected genomic regions. Both steps employ a deep convolutional neural network. The network architecture accounts for the structure of genome data by applying convolution only to parts of the data where this makes sense from a genomics perspective.

resultsOur approach identifies potentially ALS-associated promoter regions, and generally outperforms other classification methods. Test results support the hypothesis that non-additive combinations of variants contribute to ALS. Architectures and protocols developed are tailored toward processing population-scale, whole-genome data. We consider this a relevant first step toward deep learning assisted genotype-phenotype association in whole genome-sized data. AVAILABILITY AND IMPLEMENTATION: Our code will be available on Github, together with a synthetic dataset (https://github.com/byin-cwi/ALS-Deeplearning). The data used in this study is available to bona-fide researchers upon request. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Amyotrophic Lateral SclerosisGenomeNeural Networks, ComputerNeurodegenerative DiseasesGenotypeHumans

Identifiers

PMID31510706
PMCPMC6612814
OpenAlexW2960151627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.